These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2128053)

  • 21. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
    Larsen PR
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperresponse to thyrotropin-releasing hormone accompanying small decreases in serum thyroid hormone concentrations.
    Vagenakis AG; Rapoport B; Azizi F; Portnay GI; Braverman LE; Ingbar SH
    J Clin Invest; 1974 Oct; 54(4):913-8. PubMed ID: 4214837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The thyroidal T4/T3 ratio and its regulation in non-toxic goitre.
    Reinwein D; Durrer HA; Wiermann H; Löhnert J; von zur Mühlen A
    Horm Metab Res; 1976 Sep; 8(5):394-9. PubMed ID: 824192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on the TRH test on the patients with Graves' disease during the treatment with antithyroid drug (author's transl)].
    Enomoto K; Inoue K; Enomoto H
    Nihon Naibunpi Gakkai Zasshi; 1975 Dec; 51(12):1052-64. PubMed ID: 823053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease.
    Uy HL; Reasner CA; Samuels MH
    Am J Med; 1995 Aug; 99(2):173-9. PubMed ID: 7625422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe but not mild alterations of thyroid function modulate the density of thyroid-stimulating hormone receptors in the rat thyroid gland.
    Denereaz N; Lemarchand-Beraud T
    Endocrinology; 1995 Apr; 136(4):1694-700. PubMed ID: 7895680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chronologic study of free T3 and T4, of responses to TRH and of the suppression test during treatment of Basedow's disease].
    Jaffiol C; Baldet L; Castelnau P; Aberlenc M; Mirouze J
    Ann Endocrinol (Paris); 1978; 39(1):61-2. PubMed ID: 418732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroidal response to an increase or decrease of endogenous TSH in patients with hyperthyroidism and its correlation with TSH binding inhibiting immunoglobulin.
    Katakura M; Koizumi Y; Aizawa T; Takasu N; Yamada T; Yukimura Y; Nagata H
    Clin Exp Pharmacol Physiol; 1986 May; 13(5):407-15. PubMed ID: 2874908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in circulating thyroid hormones and thyrotropin in euthyroid patients with Graves' disease after total thyroidectomy: comparison between responders and nonresponders to TSH-releasing hormone.
    Tamai H; Mori K; Matsubayashi S; Hirota Y; Kobayashi A; Matsuzuka F; Kuma K; Kumagai LF; Nagataki S
    Metabolism; 1985 Nov; 34(11):1024-8. PubMed ID: 3932818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the pathophysiological role of thyroidal prostaglandin E (PGE) in Graves' disease.
    Yamamoto M; Rapoport B; Clark OH; Feingold K
    Horm Metab Res; 1980; 12(6):256-60. PubMed ID: 6893314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in responsivity to TRH test and T3-suppression test after surgical treatment of hyperthyroidism (author's transl)].
    Tamai H; Fujino R; Shizume K; Kuma K; Suematsu H
    Nihon Naibunpi Gakkai Zasshi; 1975 Dec; 51(12):985-96. PubMed ID: 823054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A radioimmunoassay for 3,3',5'-L-triiodothyronine (reverse T3): assessment of thyroid gland content and serum measurements in conditions of normal and altered thyroidal economy and following administration of thyrotropin releasing hormone (TRH) and thyrotropin (TSH).
    Burman KD; Dimond RC; Wright FD; Earll JM; Bruton J; Wartofsky L
    J Clin Endocrinol Metab; 1977 Apr; 44(4):660-72. PubMed ID: 191466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma free triiodothyronine response to thyrotropin-releasing hormone to predict the remission of Graves' disease treated with antithyroid drugs.
    Notsu K; Oka N; Masaki Y; Furuya H; Kato Y
    J Clin Endocrinol Metab; 1991 Aug; 73(2):396-400. PubMed ID: 1713218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [TRH and T3 suppression tests after 131I therapy of thyrotoxicosis (author's transl)].
    Tamai H; Tsushimi T; Shizume K; Kuma K; Suematsu H
    Nihon Naibunpi Gakkai Zasshi; 1976 Mar; 52(3):232-42. PubMed ID: 823056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship among thyrotropin (TSH), thyroid stimulating immunoglobulins, and results of triiodothyronine (T3) suppression test in patients with Graves' disease.
    Horimoto M; Nishikawa M; Uno C; Yoshikawa N; Taniguchi N; Inada M
    Endocrinol Jpn; 1988 Dec; 35(6):841-8. PubMed ID: 2471633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
    Ito M; Kawasaki M; Danno H; Kohsaka K; Nakamura T; Hisakado M; Yoshioka W; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Nakamura H; Miyauchi A
    Thyroid; 2019 Oct; 29(10):1364-1370. PubMed ID: 31411123
    [No Abstract]   [Full Text] [Related]  

  • 38. [Serum thyroid hormones and TSH response to TRH during treatment of Graves' disease by carbimazole (author's transl)].
    Lorcy Y; Heim J; Auvray E; Allannic H
    Ann Endocrinol (Paris); 1979; 40(4):441-2. PubMed ID: 117739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thyroidal response to thyrotropin-releasing hormone (TRH) as a predictive test of remission in euthyroid patients with Graves' disease].
    Takahashi H
    Fukuoka Igaku Zasshi; 1984 May; 75(5):241-51. PubMed ID: 6436156
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study of the thyroid function by the I-M TRH test (2 mg) (author's transl)].
    Fournier M; Orgiazzi J; Magnon-Pujo B; Quintana J; Mornex R
    Ann Endocrinol (Paris); 1978; 39(1):59-60. PubMed ID: 418731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.